Niger vs South-East Asia (WHO region): Treatment success rate: XDR-TB cases
Niger
100
in 2022
South-East Asia (WHO region)
73
in 2022
Niger rank
1st
South-East Asia (WHO region) rank
2nd
Treatment success rate: XDR-TB cases over time
- Niger
- South-East Asia (WHO region)
How they compare
Niger currently reports 100 against 73 in South-East Asia (WHO region), a difference of 27.
That makes Niger's figure about 1.4 times South-East Asia (WHO region)'s.
The two have swapped places 1 time across 8 shared years of data; in 2011 it was South-East Asia (WHO region) ahead.
Niger ranks 1st and South-East Asia (WHO region) ranks 2nd of 82 countries.
Niger has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Niger | South-East Asia (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 80 | 38 | 42 | Niger |
| 2020s | 100 | 69 | 31 | Niger |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate: xdr-tb cases, Niger or South-East Asia (WHO region)?
- Niger, at 100 against 73 in South-East Asia (WHO region) as of 2022.
- What is the difference in treatment success rate: xdr-tb cases between Niger and South-East Asia (WHO region)?
- 27, with Niger ahead.
- How many years of comparable data are there for Niger and South-East Asia (WHO region)?
- 8 years are reported by both, from 2011 to 2022.
- How do Niger and South-East Asia (WHO region) rank globally for treatment success rate: xdr-tb cases?
- Niger ranks 1st and South-East Asia (WHO region) ranks 2nd of 82 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate: XDR-TB cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.